CD8A and infection: Treatment with bNAbs in lieu of ART very early in infection has previously been shown to induce virologic control in slightly more than half of SHIV-infected macaques through a CD8+ T-cell-dependent mechanism15,16, indicating a treatment strategy incorporating early immunologic interventions may also be of use in combination with later treatments.